Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism
Completed
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
N/A
2005-12-01
The two purposes of this study are
1. to determine what effect the chronic and moderate/heavy drinking of alcoholic beverages
has
1. on the blood level of bupropion and chlorzoxazone and their major breakdown
products in the blood and
2. on the stimulant effect of bupropion and
2. to determine what effect a normal and common (25% frequency) genetic variation of a
specific liver enzyme (that breaks down bupropion) has
1. on the blood levels of bupropion and its major breakdown products in the blood and
2. on the stimulant effect of bupropion.
Two groups of volunteers will be recruited for this study:
1. volunteers who drink moderate to heavy amounts of alcohol frequently and
2. volunteers who usually do not drink alcohol.
Volunteers will NOT be asked to change their drinking (or nondrinking) habits during the
study.
Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes
Completed
University Hospital, Basel, Switzerland
Phase 1
2010-07-01
The purpose of this study is to assess whether a cocktail of seven approved drugs (so-called
"Basel cocktail") can be used for simultaneous phenotyping of CYP1A2, CYP2B6, CYP2C9,
CYP2C19, CYP2D6, CYP2E1 and CYP3A4.
Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake
Completed
University of California, San Francisco
Phase 4
2011-04-01
The overall goals of this study are to (1) expand knowledge about interactions of
chlorzoxazone with alcohol by assessing the effects of chlorzoxazone compared to placebo in
moderate and heavy social alcohol users and (2) to compare the effects of chlorzoxazone on
visual cue induced alcohol craving to placebo in moderate to heavy social alcohol users.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.